HomeONCT • NASDAQ
add
Oncternal Therapeutics Inc
Previous close
$0.75
Day range
$0.73 - $0.80
Year range
$0.62 - $13.00
Market cap
3.36M USD
Avg Volume
174.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 494.00K | 175.98% |
Operating expense | 2.33M | -24.79% |
Net income | -8.46M | 14.18% |
Net profit margin | -1.71K | 68.90% |
Earnings per share | -2.86 | 15.88% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.58M | -63.83% |
Total assets | 15.60M | -63.88% |
Total liabilities | 6.45M | 4.10% |
Total equity | 9.15M | — |
Shares outstanding | 2.96M | — |
Price to book | 0.24 | — |
Return on assets | -96.06% | — |
Return on capital | -149.66% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -8.46M | 14.18% |
Cash from operations | -6.95M | -26.12% |
Cash from investing | 13.65M | 193.23% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | 6.70M | 838.37% |
Free cash flow | -3.53M | -70.13% |
About
Founded
1997
Website
Employees
27
